Company Filing History:
1 out of 19 
1 out of 832,912 Years Active: 2008-2010
Title: Carsten Germansen: Innovator in PEGylated G-CSF Polypeptides
Introduction
Carsten Germansen is a notable inventor based in Herlev, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of PEGylated G-CSF polypeptides. With a total of two patents to his name, Germansen's work focuses on enhancing the stability and uniformity of these important polypeptides.
Latest Patents
Germansen's latest patents include innovative methods for increasing the stability and uniformity of PEGylated G-CSF polypeptides. One patent describes a method that involves subjecting the polypeptide to an elevated pH above 8.0 for a suitable period to remove PEG moieties attached to a hydroxyl group. This is followed by reducing the pH to about 8.0 or lower. The second patent also focuses on compositions comprising mixtures of positional PEG isomers of PEGylated G-CSF, utilizing similar methods to enhance the polypeptides' effectiveness in increasing neutrophil levels in patients.
Career Highlights
Throughout his career, Carsten Germansen has worked with various companies, including Maxygen Holdings Ltd. His experience in the industry has allowed him to develop and refine his innovative approaches to biochemistry.
Collaborations
Germansen has collaborated with notable professionals in his field, including Bobby Soni and Grethe Norskov Rasmussen. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Carsten Germansen's work in the field of PEGylated G-CSF polypeptides showcases his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to enhancing the stability and effectiveness of important biopharmaceuticals.